Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentric, Double-blind, Placebo Controlled Clinical Trial With 5-hydroxytryptophan (5-HTP) in Patients With Inflammatory Bowel Disease in Clinical and Biologic Remission: Effect on Fatigue Scores

NCT03574948 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT03574948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03574948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentric, Double-blind, Placebo Controlled Clinical Trial With 5-hydroxytryptophan (5-HTP) in Patients With Inflammatory Bowel Disease in Clinical and Biologic Remission: Effect on Fatigue Scores
Lead sponsor
University Hospital, Ghent
Phase
Phase 2
Overall status
Completed
Start date
December 6, 2018
Completion date
March 3, 2021
Enrollment
175 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, fatigue, remission, ulcerative colitis